{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T15:52:10Z","timestamp":1794585130743,"version":"4.9.1"},"reference-count":247,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1038\/s41584-020-00506-w","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T11:02:54Z","timestamp":1601982174000},"page":"645-660","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":736,"title":["Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8673-5133","authenticated-orcid":false,"given":"Piercarlo","family":"Sarzi-Puttini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0369-1700","authenticated-orcid":false,"given":"Valeria","family":"Giorgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3255-3307","authenticated-orcid":false,"given":"Daniela","family":"Marotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola","family":"Atzeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,6]]},"reference":[{"key":"506_CR1","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s11916-013-0356-5","volume":"17","author":"LP Queiroz","year":"2013","unstructured":"Queiroz, L. P. Worldwide epidemiology of fibromyalgia. Curr. Pain. Headache Rep. 17, 356 (2013).","journal-title":"Curr. Pain. Headache Rep."},{"key":"506_CR2","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/art.38905","volume":"67","author":"GT Jones","year":"2015","unstructured":"Jones, G. T. et al. The prevalence of fibromyalgia in the general population: a comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria. Arthritis Rheumatol. 67, 568\u2013575 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"506_CR3","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/ejp.1367","volume":"23","author":"S Perrot","year":"2019","unstructured":"Perrot, S. Fibromyalgia: a misconnection in a multiconnected world? Eur. J. Pain. 23, 866\u2013873 (2019).","journal-title":"Eur. J. Pain."},{"key":"506_CR4","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/annrheumdis-2016-209724","volume":"76","author":"GJ Macfarlane","year":"2017","unstructured":"Macfarlane, G. J. et al. EULAR revised recommendations for the management of fibromyalgia. Ann. Rheum. Dis. 76, 318\u2013328 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"506_CR5","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.semarthrit.2008.12.003","volume":"39","author":"JC Branco","year":"2009","unstructured":"Branco, J. C. et al. Prevalence of fibromyalgia: a survey in five European countries. Semin. Arthritis Rheum. 39, 448\u2013453 (2009).","journal-title":"Semin. Arthritis Rheum."},{"key":"506_CR6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1756-185X.2011.01682.x","volume":"15","author":"M Chaaya","year":"2011","unstructured":"Chaaya, M. et al. High burden of rheumatic diseases in Lebanon: a COPCORD study. Int. J. Rheum. Dis. 15, 136\u2013143 (2011).","journal-title":"Int. J. Rheum. Dis."},{"key":"506_CR7","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/acr.22277","volume":"66","author":"I Nakamura","year":"2014","unstructured":"Nakamura, I. et al. An epidemiologic internet survey of fibromyalgia and chronic pain in Japan. Arthritis Care Res. 66, 1093\u20131101 (2014).","journal-title":"Arthritis Care Res."},{"key":"506_CR8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/10582450802161820","volume":"16","author":"AD Turhanoglu","year":"2008","unstructured":"Turhanoglu, A. D. et al. The epidemiological aspects of fibromyalgia syndrome in adults living in Turkey: a population based study. J. Musculoskelet. Pain 16, 141\u2013147 (2008).","journal-title":"J. Musculoskelet. Pain"},{"key":"506_CR9","first-page":"806","volume":"86","author":"M Guermazi","year":"2008","unstructured":"Guermazi, M. et al. [Fibromyalgia prevalence in Tunisia]. Tunis. Med. 86, 806\u2013811 (2008).","journal-title":"Tunis. Med."},{"key":"506_CR10","first-page":"594","volume":"31","author":"E Rodrigues Senna","year":"2004","unstructured":"Rodrigues Senna, E. et al. Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach. J. Rheumatol. 31, 594\u2013597 (2004).","journal-title":"J. Rheumatol."},{"key":"506_CR11","first-page":"1570","volume":"26","author":"KP White","year":"1999","unstructured":"White, K. P., Speechley, M., Harth, M. & Ostbye, T. The London fibromyalgia epidemiology study: the prevalence of fibromyalgia syndrome in London, Ontario. J. Rheumatol. 26, 1570\u20131576 (1999).","journal-title":"J. Rheumatol."},{"key":"506_CR12","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/acr.21896","volume":"65","author":"A Vincent","year":"2013","unstructured":"Vincent, A. et al. Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester epidemiology project. Arthritis Care Res. 65, 786\u2013792 (2013).","journal-title":"Arthritis Care Res."},{"key":"506_CR13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1300\/J094v14n02_02","volume":"14","author":"RA Scudds","year":"2006","unstructured":"Scudds, R. A., Li, E. K. M. & Scudds, R. J. The prevalence of fibromyalgia syndrome in Chinese people in Hong Kong. J. Musculoskelet. Pain 14, 3\u201311 (2006).","journal-title":"J. Musculoskelet. Pain"},{"key":"506_CR14","first-page":"39","volume":"30","author":"JN Ablin","year":"2012","unstructured":"Ablin, J. N. et al. Prevalence of fibromyalgia in the Israeli population: a population-based study to estimate the prevalence of fibromyalgia in the Israeli population using the London Fibromyalgia Epidemiology Study Screening Questionnaire (LFESSQ). Clin Exp Rheumatol 30, 39\u201343 (2012).","journal-title":"Clin Exp Rheumatol"},{"key":"506_CR15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/03009749309095129","volume":"22","author":"E Prescott","year":"1993","unstructured":"Prescott, E. et al. Fibromyalgia in the adult danish population. I. A prevalence study. Scand. J. Rheumatol. 22, 233\u2013237 (1993).","journal-title":"Scand. J. Rheumatol."},{"key":"506_CR16","first-page":"819","volume":"23","author":"F Salaffi","year":"2005","unstructured":"Salaffi, F. et al. Prevalence of musculoskeletal conditions in an Italian population sample: Results of a regional community-based study. I. The MAPPING study. Clin. Exp. Rheumatol. 23, 819\u2013828 (2005).","journal-title":"Clin. Exp. Rheumatol."},{"key":"506_CR17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/ar2715","volume":"11","author":"M Spaeth","year":"2009","unstructured":"Spaeth, M. Epidemiology, costs, and the economic burden of fibromyalgia. Arthritis Res. Ther. 11, 2\u20133 (2009).","journal-title":"Arthritis Res. Ther."},{"key":"506_CR18","first-page":"90","volume":"37","author":"W H\u00e4user","year":"2019","unstructured":"H\u00e4user, W., Sarzi-Puttini, P. & Fitzcharles, M. A. Fibromyalgia syndrome: under-, over- and misdiagnosis. Clin. Exp. Rheumatol. 37, 90\u201397 (2019).","journal-title":"Clin. Exp. Rheumatol."},{"key":"506_CR19","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/AJP.0b013e3181cf599f","volume":"26","author":"J Lachaine","year":"2010","unstructured":"Lachaine, J., Beauchemin, C. & Landry, P.-A. Clinical and economic characteristics of patients with fibromyalgia syndrome. Clin. J. Pain 26, 284\u2013290 (2010).","journal-title":"Clin. J. Pain"},{"key":"506_CR20","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/j.1742-1241.2007.01480.x","volume":"61","author":"A Berger","year":"2007","unstructured":"Berger, A., Dukes, E., Martin, S., Edelsberg, J. & Oster, G. Characteristics and healthcare costs of patients with fibromyalgia syndrome. Int. J. Clin. Pract. 61, 1498\u20131508 (2007).","journal-title":"Int. J. Clin. Pract."},{"key":"506_CR21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2147\/CEOR.S41111","volume":"5","author":"T Knight","year":"2013","unstructured":"Knight, T. et al. Health-resource use and costs associated with fibromyalgia in France, Germany, and the United States. Clinicoecon. Outcomes Res. 5, 171\u2013180 (2013).","journal-title":"Clinicoecon. Outcomes Res."},{"key":"506_CR22","doi-asserted-by":"crossref","DOI":"10.1186\/s12891-016-1027-6","volume":"17","author":"A Lacasse","year":"2016","unstructured":"Lacasse, A., Bourgault, P. & Choini\u00e8re, M. Fibromyalgia-related costs and loss of productivity: a substantial societal burden. BMC Musculoskelet. Disord. 17, 168 (2016).","journal-title":"BMC Musculoskelet. Disord."},{"key":"506_CR23","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/imj.13135","volume":"46","author":"EK Guymer","year":"2016","unstructured":"Guymer, E. K., Littlejohn, G. O., Brand, C. K. & Kwiatek, R. A. Fibromyalgia onset has a high impact on work ability in Australians. Intern. Med. J. 46, 1069\u20131074 (2016).","journal-title":"Intern. Med. J."},{"key":"506_CR24","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S1521-6942(03)00036-6","volume":"17","author":"RH Gracely","year":"2003","unstructured":"Gracely, R. H., Grant, M. A. & Giesecke, T. Evoked pain measures in fibromyalgia. Best Pract. Res. Clin. Rheumatol. 17, 593\u2013609 (2003).","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"506_CR25","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2377-11-55","volume":"11","author":"J Koroschetz","year":"2011","unstructured":"Koroschetz, J. et al. Fibromyalgia and neuropathic pain \u2014 differences and similarities. A comparison of 3057 patients with diabetic painful neuropathy and fibromyalgia. BMC Neurol. 11, 55 (2011).","journal-title":"BMC Neurol."},{"key":"506_CR26","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/rheumatology\/keq066","volume":"49","author":"SE Rehm","year":"2010","unstructured":"Rehm, S. E. et al. A cross-sectional survey of 3035 patients with fibromyalgia: subgroups of patients with typical comorbidities and sensory symptom profiles. Rheumatology 49, 1146\u20131152 (2010).","journal-title":"Rheumatology"},{"key":"506_CR27","first-page":"S117","volume":"33","author":"A Rossi","year":"2015","unstructured":"Rossi, A. et al. Fibromyalgia and nutrition: what news? Clin. Exp. Rheumatol. 33, S117\u2013S125 (2015).","journal-title":"Clin. Exp. Rheumatol."},{"key":"506_CR28","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/acr.22008","volume":"65","author":"ER Bossema","year":"2013","unstructured":"Bossema, E. R., Van Middendorp, H., Jacobs, J. W. G., Bijlsma, J. W. J. & Geenen, R. Influence of weather on daily symptoms of pain and fatigue in female patients with fibromyalgia: a multilevel regression analysis. Arthritis Care Res. 65, 1019\u20131025 (2013).","journal-title":"Arthritis Care Res."},{"key":"506_CR29","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.jpain.2010.03.011","volume":"11","author":"R Staud","year":"2010","unstructured":"Staud, R., Robinson, M. E., Weyl, E. E. & Price, D. D. Pain variability in fibromyalgia is related to activity and rest: role of peripheral tissue impulse input. J. Pain 11, 1376\u20131383 (2010).","journal-title":"J. Pain"},{"key":"506_CR30","first-page":"105","volume":"37","author":"R Casale","year":"2019","unstructured":"Casale, R. et al. Fibromyalgia and the concept of resilience. Clin. Exp. Rheumatol. 37, 105\u2013113 (2019).","journal-title":"Clin. Exp. Rheumatol."},{"key":"506_CR31","doi-asserted-by":"crossref","first-page":"109","DOI":"10.5152\/eurjrheum.2015.0029","volume":"2","author":"SC Sand\u0131k\u00e7\u0131","year":"2015","unstructured":"Sand\u0131k\u00e7\u0131, S. C. & \u00d6zbalkan, Z. Fatigue in rheumatic diseases. Eur. J. Rheumatol. 2, 109\u2013113 (2015).","journal-title":"Eur. J. Rheumatol."},{"key":"506_CR32","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12955-014-0111-6","volume":"12","author":"L Kleinman","year":"2014","unstructured":"Kleinman, L. et al. Assessment of sleep in patients with fibromyalgia: qualitative development of the fibromyalgia sleep diary. Health Qual. Life Outcomes 12, 111 (2014).","journal-title":"Health Qual. Life Outcomes"},{"key":"506_CR33","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2474-8-27","volume":"8","author":"RM Bennett","year":"2007","unstructured":"Bennett, R. M., Jones, J., Turk, D. C., Russell, I. J. & Matallana, L. An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet. Disord. 8, 27 (2007).","journal-title":"BMC Musculoskelet. Disord."},{"key":"506_CR34","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.rdc.2009.06.002","volume":"35","author":"JM Glass","year":"2009","unstructured":"Glass, J. M. Review of cognitive dysfunction in fibromyalgia: a convergence on working memory and attentional control impairments. Rheum. Dis. Clin. North Am. 35, 299\u2013311 (2009).","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"506_CR35","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.3899\/jrheum.110026","volume":"38","author":"B Walitt","year":"2011","unstructured":"Walitt, B. et al. The longitudinal outcome of fibromyalgia: a study of 1555 patients. J. Rheumatol. 38, 2238\u20132246 (2011).","journal-title":"J. Rheumatol."},{"key":"506_CR36","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1468-2982.2005.01060.x","volume":"26","author":"G Ifergane","year":"2006","unstructured":"Ifergane, G., Buskila, D., Simiseshvely, N., Zeev, K. & Cohen, H. Prevalence of fibromyalgia syndrome in migraine patients. Cephalalgia 26, 451\u2013456 (2006).","journal-title":"Cephalalgia"},{"key":"506_CR37","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/S0399-8320(09)71521-0","volume":"33","author":"N Mathieu","year":"2009","unstructured":"Mathieu, N. [Somatic comorbidities in irritable bowel syndrome: fibromyalgia, chronic fatigue syndrome, and interstitial cystitis]. Gastroenterol. Clin. Biol. 33, S17\u2013S25 (2009).","journal-title":"Gastroenterol. Clin. Biol."},{"key":"506_CR38","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.juro.2010.06.005","volume":"184","author":"JC Nickel","year":"2010","unstructured":"Nickel, J. C. et al. Interstitial cystitis\/painful bladder syndrome and associated medical conditions with an emphasis on irritable bowel syndrome, fibromyalgia and chronic fatigue syndrome. J. Urol. 184, 1358\u20131363 (2010).","journal-title":"J. Urol."},{"key":"506_CR39","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10067-009-1093-3","volume":"28","author":"L Kalichman","year":"2009","unstructured":"Kalichman, L. Association between fibromyalgia and sexual dysfunction in women. Clin. Rheumatol. 28, 365\u2013369 (2009).","journal-title":"Clin. Rheumatol."},{"key":"506_CR40","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jpain.2018.10.008","volume":"20","author":"LM Arnold","year":"2018","unstructured":"Arnold, L. M. et al. AAPT diagnostic criteria for fibromyalgia. J. Pain 20, 611\u2013628 (2018).","journal-title":"J. Pain"},{"key":"506_CR41","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/RHU.0b013e3181a1083d","volume":"15","author":"C Solano","year":"2009","unstructured":"Solano, C. et al. Autonomic dysfunction in fibromyalgia assessed by the composite autonomic symptoms scale (COMPASS). J. Clin. Rheumatol. 15, 172\u2013176 (2009).","journal-title":"J. Clin. Rheumatol."},{"key":"506_CR42","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/RHU.0b013e3182a225dd","volume":"20","author":"A Vincent","year":"2014","unstructured":"Vincent, A. et al. A report of the autonomic symptom profile in patients with fibromyalgia. J. Clin. Rheumatol. 20, 106\u2013108 (2014).","journal-title":"J. Clin. Rheumatol."},{"key":"506_CR43","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","volume":"33","author":"F Wolfe","year":"1990","unstructured":"Wolfe, F. et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 33, 160\u2013172 (1990).","journal-title":"Arthritis Rheum."},{"key":"506_CR44","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1136\/bmj.312.7042.1339","volume":"312","author":"MB Yunus","year":"1996","unstructured":"Yunus, M. B. & Aldag, J. C. Restless legs syndrome and leg cramps in fibromyalgia syndrome: a controlled study. BMJ 312, 1339 (1996).","journal-title":"BMJ"},{"key":"506_CR45","doi-asserted-by":"crossref","first-page":"423","DOI":"10.5664\/jcsm.27929","volume":"6","author":"M Viola-Saltzman","year":"2010","unstructured":"Viola-Saltzman, M., Watson, N. F., Bogart, A., Goldberg, J. & Buchwald, D. High prevalence of restless legs syndrome among patients with fibromyalgia: a controlled cross-sectional study. J. Clin. Sleep Med. 6, 423\u2013427 (2010).","journal-title":"J. Clin. Sleep Med."},{"key":"506_CR46","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000180313","volume":"61","author":"R Stehlik","year":"2009","unstructured":"Stehlik, R., Arvidsson, L. & Ulfberg, J. Restless legs syndrome is common among female patients with fibromyalgia. Eur. Neurol. 61, 107\u2013111 (2009).","journal-title":"Eur. Neurol."},{"key":"506_CR47","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/RHU.0b013e318190f991","volume":"15","author":"KD Jones","year":"2009","unstructured":"Jones, K. D., Horak, F. B., Winters-Stone, K., Irvine, J. M. & Bennett, R. M. Fibromyalgia is associated with impaired balance and falls. J. Clin. Rheumatol. 15, 16\u201321 (2009).","journal-title":"J. Clin. Rheumatol."},{"key":"506_CR48","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2147\/PRBM.S178240","volume":"12","author":"CM Galvez-S\u00e1nchez","year":"2019","unstructured":"Galvez-S\u00e1nchez, C. M., Duschek, S. & Del Paso, G. A. R. Psychological impact of fibromyalgia: current perspectives. Psychol. Res. Behav. Manag. 12, 117\u2013127 (2019).","journal-title":"Psychol. Res. Behav. Manag."},{"key":"506_CR49","first-page":"295","volume":"38","author":"E Gonz\u00e1lez","year":"2010","unstructured":"Gonz\u00e1lez, E., Elorza, J. & Failde, I. Fibromyalgia and psychiatric comorbidity: their effect on the quality of life patients. Actas Esp. Psiquiatr. 38, 295\u2013300 (2010).","journal-title":"Actas Esp. Psiquiatr."},{"key":"506_CR50","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1001\/jama.289.23.3095","volume":"289","author":"RC Kessler","year":"2003","unstructured":"Kessler, R. C. et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289, 3095\u20133105 (2003).","journal-title":"JAMA"},{"key":"506_CR51","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1002\/art.27623","volume":"62","author":"L Dreyer","year":"2010","unstructured":"Dreyer, L., Kendall, S., Danneskiold-Sams\u00f8e, B., Bartels, E. M. & Bliddal, H. Mortality in a cohort of Danish patients with fibromyalgia: Increased frequency of suicide. Arthritis Rheum. 62, 3101\u20133108 (2010).","journal-title":"Arthritis Rheum."},{"key":"506_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2020.110078","author":"H Gill","year":"2020","unstructured":"Gill, H. et al. The prevalence of suicidal behaviour in fibromyalgia patients. Prog. Neuropsychopharmacol. Biol. Psychiatry https:\/\/doi.org\/10.1016\/j.pnpbp.2020.110078 (2020).","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"506_CR53","first-page":"405","volume":"134","author":"RM Bennett","year":"1981","unstructured":"Bennett, R. M. Fibrositis: misnomer for a common rheumatic disorder. West. J. Med. 134, 405\u2013413 (1981).","journal-title":"West. J. Med."},{"key":"506_CR54","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3899\/jrheum.100594","volume":"38","author":"F Wolfe","year":"2011","unstructured":"Wolfe, F. et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgia. J. Rheumatol. 38, 1113\u20131122 (2011).","journal-title":"J. Rheumatol."},{"key":"506_CR55","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.20140","volume":"62","author":"F Wolfe","year":"2010","unstructured":"Wolfe, F. et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res. 62, 600\u2013610 (2010).","journal-title":"Arthritis Care Res."},{"key":"506_CR56","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","volume":"46","author":"F Wolfe","year":"2016","unstructured":"Wolfe, F. et al. 2016 Revisions to the 2010\/2011 fibromyalgia diagnostic criteria. Semin. Arthritis Rheum. 46, 319\u2013329 (2016).","journal-title":"Semin. Arthritis Rheum."},{"key":"506_CR57","first-page":"S3","volume":"37","author":"F Atzeni","year":"2019","unstructured":"Atzeni, F. et al. One year in review 2019: fibromyalgia. Clin. Exp. Rheumatol. 37, S3\u2013S10 (2019).","journal-title":"Clin. Exp. Rheumatol."},{"key":"506_CR58","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.pain.2010.03.034","volume":"150","author":"S Perrot","year":"2010","unstructured":"Perrot, S., Bouhassira, D. & Fermanian, J. Development and validation of the fibromyalgia rapid screening tool (FiRST). Pain 150, 250\u2013256 (2010).","journal-title":"Pain"},{"key":"506_CR59","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12955-014-0128-x","volume":"12","author":"R Baron","year":"2014","unstructured":"Baron, R. et al. Improving the primary care physicians\u2019 decision making for fibromyalgia in clinical practice: development and validation of the fibromyalgia detection (FibroDetect\u00ae) screening tool. Health Qual. Life Outcomes 12, 128 (2014).","journal-title":"Health Qual. Life Outcomes"},{"key":"506_CR60","first-page":"9","volume":"38","author":"F Salaffi","year":"2019","unstructured":"Salaffi, F. et al. Development and validation of the SImple FIbromyalgia Screening questionnaire for improving the recognition of fibromyalgia in daily practice. Clin. Exp. Rheumatol. 38, 9\u201316 (2019).","journal-title":"Clin. Exp. Rheumatol."},{"key":"506_CR61","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.semarthrit.2007.09.003","volume":"37","author":"MB Yunus","year":"2008","unstructured":"Yunus, M. B. Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness. Semin. Arthritis Rheum. 37, 339\u2013352 (2008).","journal-title":"Semin. Arthritis Rheum."},{"key":"506_CR62","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/art.24553","volume":"61","author":"F Wolfe","year":"2009","unstructured":"Wolfe, F. Fibromyalgianess. Arthritis Care Res. 61, 715\u2013716 (2009).","journal-title":"Arthritis Care Res."},{"key":"506_CR63","first-page":"1074","volume":"36","author":"F Salaffi","year":"2018","unstructured":"Salaffi, F., Di Carlo, M., Arc\u00e0, S. & Galeazzi, M. Categorisation of disease severity states in fibromyalgia: a first step to support decision-making in health care policy. Clin. Exp. Rheumatol. 36, 1074\u20131081 (2018).","journal-title":"Clin. Exp. Rheumatol."},{"key":"506_CR64","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.2147\/JPR.S147199","volume":"11","author":"F Davis","year":"2018","unstructured":"Davis, F. et al. Characterizing classes of fibromyalgia within the continuum of central sensitization syndrome. J. Pain Res. 11, 2551\u20132560 (2018).","journal-title":"J. Pain Res."},{"key":"506_CR65","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1056\/NEJMp1507136","volume":"373","author":"JC Ballantyne","year":"2015","unstructured":"Ballantyne, J. C. & Sullivan, M. D. Intensity of chronic pain \u2014 the wrong metric? N. Engl. J. Med. 373, 2098\u20132099 (2015).","journal-title":"N. Engl. J. Med."},{"key":"506_CR66","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.berh.2011.01.004","volume":"25","author":"F Salaffi","year":"2011","unstructured":"Salaffi, F., Sarzi-Puttini, P., Ciapetti, A. & Atzeni, F. Clinimetric evaluations of patients with chronic widespread pain. Best Pract. Res. Clin. Rheumatol. 25, 249\u2013270 (2011).","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"506_CR67","first-page":"728","volume":"18","author":"CS Burckhardt","year":"1991","unstructured":"Burckhardt, C. S., Clark, S. R. & Bennett, R. M. The fibromyalgia impact questionnaire: development and validation. J. Rheumatol. 18, 728\u2013733 (1991).","journal-title":"J. Rheumatol."},{"key":"506_CR68","doi-asserted-by":"crossref","first-page":"R120","DOI":"10.1186\/ar2783","volume":"11","author":"RM Bennett","year":"2009","unstructured":"Bennett, R. M. et al. The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties. Arthritis Res. Ther. 11, R120 (2009).","journal-title":"Arthritis Res. Ther."},{"key":"506_CR69","first-page":"S41","volume":"31","author":"F Salaffi","year":"2013","unstructured":"Salaffi, F. et al. Psychometric characteristics of the Italian version of the revised Fibromyalgia Impact Questionnaire using classical test theory and Rasch analysis. Clin. Exp. Rheumatol. 31, S41\u2013S49 (2013).","journal-title":"Clin. Exp. Rheumatol."},{"key":"506_CR70","doi-asserted-by":"crossref","first-page":"R125","DOI":"10.1186\/ar2792","volume":"11","author":"F Salaffi","year":"2009","unstructured":"Salaffi, F. et al. Development and validation of the self-administered Fibromyalgia Assessment Status: a disease-specific composite measure for evaluating treatment effect. Arthritis Res. Ther. 11, R125 (2009).","journal-title":"Arthritis Res. Ther."},{"key":"506_CR71","first-page":"S49","volume":"29","author":"C Iannuccelli","year":"2011","unstructured":"Iannuccelli, C. et al. Psychometric properties of the Fibromyalgia Assessment Status (FAS) index: a national web-based study of fibromyalgia. Clin. Exp. Rheumatol. 29, S49\u2013S54 (2011).","journal-title":"Clin. Exp. Rheumatol."},{"key":"506_CR72","volume":"7","author":"W H\u00e4user","year":"2012","unstructured":"H\u00e4user, W. et al. Validation of the fibromyalgia survey questionnaire within a cross-sectional survey. PLoS ONE 7, e37504 (2012).","journal-title":"PLoS ONE"},{"key":"506_CR73","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jpsychores.2014.01.009","volume":"76","author":"W H\u00e4user","year":"2014","unstructured":"H\u00e4user, W., Br\u00e4hler, E., Wolfe, F. & Henningsen, P. Patient Health Questionnaire 15 as a generic measure of severity in fibromyalgia syndrome: surveys with patients of three different settings. J. Psychosom. Res. 76, 307\u2013311 (2014).","journal-title":"J. Psychosom. Res."},{"key":"506_CR74","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1097\/j.pain.0000000000000507","volume":"157","author":"E Kosek","year":"2016","unstructured":"Kosek, E. et al. Do we need a third mechanistic descriptor for chronic pain states? Pain 157, 1382\u20131386 (2016).","journal-title":"Pain"},{"key":"506_CR75","first-page":"27","volume":"8","author":"MB Yunus","year":"2000","unstructured":"Yunus, M. B. Central sensitivity syndromes: a unified concept for fibromyalgia and other similar maladies. J. Indian Rheumatol. Assoc. 8, 27\u201333 (2000).","journal-title":"J. Indian Rheumatol. Assoc."},{"key":"506_CR76","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s12016-015-8509-4","volume":"49","author":"AT Borchers","year":"2015","unstructured":"Borchers, A. T. & Gershwin, M. E. Fibromyalgia: a critical and comprehensive review. Clin. Rev. Allergy Immunol. 49, 100\u2013151 (2015).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"506_CR77","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/585419","author":"M Ceko","year":"2012","unstructured":"Ceko, M., Bushnell, M. C. & Gracely, R. H. Neurobiology underlying fibromyalgia symptoms. Pain Res. Treat. https:\/\/doi.org\/10.1155\/2012\/585419 (2012).","journal-title":"Pain Res. Treat."},{"key":"506_CR78","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/art.10893","volume":"48","author":"JA Desmeules","year":"2003","unstructured":"Desmeules, J. A. et al. Neurophysiologic evidence for a central sensitization in patients with fibromyalgia. Arthritis Rheum. 48, 1420\u20131429 (2003).","journal-title":"Arthritis Rheum."},{"key":"506_CR79","first-page":"152","volume":"25","author":"J S\u00f6rensen","year":"1998","unstructured":"S\u00f6rensen, J., Graven-Nielsen, T., Henriksson, K. G., Bengtsson, M. & Arendt-Nielsen, L. Hyperexcitability in fibromyalgia. J. Rheumatol. 25, 152\u2013155 (1998).","journal-title":"J. Rheumatol."},{"key":"506_CR80","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0304-3959(00)00432-2","volume":"91","author":"R Staud","year":"2001","unstructured":"Staud, R., Vierck, C. J., Cannon, R. L., Mauderli, A. P. & Price, D. D. Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain 91, 165\u2013175 (2001).","journal-title":"Pain"},{"key":"506_CR81","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0304-3959(96)03059-X","volume":"66","author":"AJ McDermid","year":"1996","unstructured":"McDermid, A. J., Rollman, G. B. & McCain, G. A. Generalized hypervigilance in fibromyalgia: evidence of perceptual amplification. Pain 66, 133\u2013144 (1996).","journal-title":"Pain"},{"key":"506_CR82","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jpain.2007.12.006","volume":"9","author":"ME Geisser","year":"2008","unstructured":"Geisser, M. E. et al. A psychophysical study of auditory and pressure sensitivity in patients with fibromyalgia and healthy controls. J. Pain 9, 417\u2013422 (2008).","journal-title":"J. Pain"},{"key":"506_CR83","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/j.pain.0000000000000450","volume":"157","author":"ME Martenson","year":"2016","unstructured":"Martenson, M. E. et al. A possible neural mechanism for photosensitivity in chronic pain. Pain 157, 868\u2013878 (2016).","journal-title":"Pain"},{"key":"506_CR84","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s11916-006-0069-0","volume":"10","author":"RE Harris","year":"2006","unstructured":"Harris, R. E. & Clauw, D. J. How do we know that the pain in fibromyalgia is \u201cReal\u201d? Curr. Pain Headache Rep. 10, 403\u2013407 (2006).","journal-title":"Curr. Pain Headache Rep."},{"key":"506_CR85","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/art.10225","volume":"46","author":"RH Gracely","year":"2002","unstructured":"Gracely, R. H., Petzke, F., Wolf, J. M. & Clauw, D. J. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum. 46, 1333\u20131343 (2002).","journal-title":"Arthritis Rheum."},{"key":"506_CR86","first-page":"364","volume":"31","author":"DB Cook","year":"2004","unstructured":"Cook, D. B. et al. Functional imaging of pain in patients with primary fibromyalgia. J. Rheumatol. 31, 364\u2013378 (2004).","journal-title":"J. Rheumatol."},{"key":"506_CR87","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.neuroimage.2008.09.008","volume":"44","author":"M Burgmer","year":"2009","unstructured":"Burgmer, M. et al. Altered brain activity during pain processing in fibromyalgia. Neuroimage 44, 502\u2013508 (2009).","journal-title":"Neuroimage"},{"key":"506_CR88","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pain.2009.03.018","volume":"144","author":"KB Jensen","year":"2009","unstructured":"Jensen, K. B. et al. Evidence of dysfunctional pain inhibition in fibromyalgia reflected in rACC during provoked pain. Pain 144, 95\u2013100 (2009).","journal-title":"Pain"},{"key":"506_CR89","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1002\/hbm.23132","volume":"37","author":"M Dehghan","year":"2016","unstructured":"Dehghan, M. et al. Coordinate-based (ALE) meta-analysis of brain activation in patients with fibromyalgia. Hum. Brain Mapp. 37, 1749\u20131758 (2016).","journal-title":"Hum. Brain Mapp."},{"key":"506_CR90","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1002\/art.27497","volume":"62","author":"V Napadow","year":"2010","unstructured":"Napadow, V. et al. Intrinsic brain connectivity in fibromyalgia is associated with chronic pain intensity. Arthritis Rheum. 62, 2545\u20132555 (2010).","journal-title":"Arthritis Rheum."},{"key":"506_CR91","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005224","volume":"4","author":"J Pujol","year":"2009","unstructured":"Pujol, J. et al. Mapping brain response to pain in fibromyalgia patients using temporal analysis of fMRI. PLoS ONE 4, e5224 (2009).","journal-title":"PLoS ONE"},{"key":"506_CR92","doi-asserted-by":"crossref","DOI":"10.1186\/1744-8069-8-32","volume":"8","author":"KB Jensen","year":"2012","unstructured":"Jensen, K. B. et al. Patients with fibromyalgia display less functional connectivity in the brain\u2019s pain inhibitory network. Mol. Pain 8, 32 (2012).","journal-title":"Mol. Pain"},{"key":"506_CR93","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.pain.2004.12.032","volume":"114","author":"N Julien","year":"2005","unstructured":"Julien, N., Goffaux, P., Arsenault, P. & Marchand, S. Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain 114, 295\u2013302 (2005).","journal-title":"Pain"},{"key":"506_CR94","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1054\/jpai.2001.25533","volume":"2","author":"CJ Vierck","year":"2001","unstructured":"Vierck, C. J. et al. The effect of maximal exercise on temporal summation of second pain (windup) in patients with fibromyalgia syndrome. J. Pain 2, 334\u2013344 (2001).","journal-title":"J. Pain"},{"key":"506_CR95","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4088\/JCP.08m04969blu","volume":"72","author":"E Normand","year":"2011","unstructured":"Normand, E. et al. Pain inhibition is deficient in chronic widespread pain but normal in major depressive disorder. J. Clin. Psychiatry 72, 219\u2013224 (2011).","journal-title":"J. Clin. Psychiatry"},{"key":"506_CR96","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1002\/art.24070","volume":"58","author":"J Lutz","year":"2008","unstructured":"Lutz, J. et al. White and gray matter abnormalities in the brain of patients with fibromyalgia: a diffusion-tensor and volumetric imaging study. Arthritis Rheum. 58, 3960\u20133969 (2008).","journal-title":"Arthritis Rheum."},{"key":"506_CR97","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/art.1780371106","volume":"37","author":"IJ Russell","year":"1994","unstructured":"Russell, I. J. et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum. 37, 1593\u20131601 (1994).","journal-title":"Arthritis Rheum."},{"key":"506_CR98","doi-asserted-by":"crossref","first-page":"10000","DOI":"10.1523\/JNEUROSCI.2849-07.2007","volume":"27","author":"RE Harris","year":"2007","unstructured":"Harris, R. E. et al. Decreased central mu-opioid receptor availability in fibromyalgia. J. Neurosci. 27, 10000\u201310006 (2007).","journal-title":"J. Neurosci."},{"key":"506_CR99","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2474-5-48","volume":"5","author":"JN Baraniuk","year":"2004","unstructured":"Baraniuk, J. N., Whalen, G., Cunningham, J. & Clauw, D. J. Cerebrospinal fluid levels of opioid peptides in fibromyalgia and chronic low back pain. BMC Musculoskelet. Disord. 5, 48 (2004).","journal-title":"BMC Musculoskelet. Disord."},{"key":"506_CR100","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/art.1780350509","volume":"35","author":"IJ Russell","year":"1992","unstructured":"Russell, I. J., Vaeroy, H., Javors, M. & Nyberg, F. Cerebrospinal fluid biogenic amine metabolites in fibromyalgia\/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum. 35, 550\u2013556 (1992).","journal-title":"Arthritis Rheum."},{"key":"506_CR101","first-page":"90","volume":"19","author":"MB Yunus","year":"1992","unstructured":"Yunus, M. B., Dailey, J. W., Aldag, J. C., Masi, A. T. & Jobe, P. C. Plasma tryptophan and other amino acids in primary fibromyalgia: a controlled study. J. Rheumatol. 19, 90\u201394 (1992).","journal-title":"J. Rheumatol."},{"key":"506_CR102","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1111\/j.1460-9568.2007.05623.x","volume":"25","author":"PB Wood","year":"2007","unstructured":"Wood, P. B. et al. Fibromyalgia patients show an abnormal dopamine response to pain. Eur. J. Neurosci. 25, 3576\u20133582 (2007).","journal-title":"Eur. J. Neurosci."},{"key":"506_CR103","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jpain.2006.05.014","volume":"8","author":"PB Wood","year":"2007","unstructured":"Wood, P. B. et al. Reduced presynaptic dopamine activity in fibromyalgia syndrome demonstrated with positron emission tomography: a pilot study. J. Pain 8, 51\u201358 (2007).","journal-title":"J. Pain"},{"key":"506_CR104","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/ar3136","volume":"12","author":"RE Harris","year":"2010","unstructured":"Harris, R. E. Elevated excitatory neurotransmitter levels in the fibromyalgia brain. Arthritis Res. Ther. 12, 141 (2010).","journal-title":"Arthritis Res. Ther."},{"key":"506_CR105","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/art.33339","volume":"64","author":"BR Foerster","year":"2012","unstructured":"Foerster, B. R. et al. Reduced insular \u03b3-aminobutyric acid in fibromyalgia. Arthritis Rheum. 64, 579\u2013583 (2012).","journal-title":"Arthritis Rheum."},{"key":"506_CR106","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/art.20042","volume":"50","author":"LM Arnold","year":"2004","unstructured":"Arnold, L. M. et al. Family study of fibromyalgia. Arthritis Rheum. 50, 944\u2013952 (2004).","journal-title":"Arthritis Rheum."},{"key":"506_CR107","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3109\/03009749209099225","volume":"21","author":"H Stormorken","year":"1992","unstructured":"Stormorken, H. & Brosstad, F. Fibromyalgia: family clustering and sensory urgency with early onset indicate genetic predisposition and thus a \u201ctrue\u201d disease. Scand. J. Rheumatol. 21, 207 (1992).","journal-title":"Scand. J. Rheumatol."},{"key":"506_CR108","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0049-0172(96)80011-4","volume":"26","author":"D Buskila","year":"1996","unstructured":"Buskila, D., Neumann, L., Hazanov, I. & Carmi, R. Familial aggregation in the fibromyalgia syndrome. Semin. Arthritis Rheum. 26, 605\u2013611 (1996).","journal-title":"Semin. Arthritis Rheum."},{"key":"506_CR109","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.berh.2015.04.018","volume":"29","author":"JN Ablin","year":"2015","unstructured":"Ablin, J. N. & Buskila, D. Update on the genetics of the fibromyalgia syndrome. Best Pract. Res. Clin. Rheumatol. 29, 20\u201328 (2015).","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"506_CR110","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/art.33338","volume":"64","author":"SB Smith","year":"2012","unstructured":"Smith, S. B. et al. Large candidate gene association study reveals genetic risk factors and therapeutic targets for fibromyalgia. Arthritis Rheum. 64, 584\u2013593 (2012).","journal-title":"Arthritis Rheum."},{"key":"506_CR111","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s00296-014-2972-8","volume":"34","author":"S Haliloglu","year":"2014","unstructured":"Haliloglu, S., Carlioglu, A., Akdeniz, D., Karaaslan, Y. & Kosar, A. Fibromyalgia in patients with other rheumatic diseases: prevalence and relationship with disease activity. Rheumatol. Int. 34, 1275\u20131280 (2014).","journal-title":"Rheumatol. Int."},{"key":"506_CR112","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.semarthrit.2017.01.005","volume":"47","author":"A Fan","year":"2017","unstructured":"Fan, A. et al. Frequency of concomitant fibromyalgia in rheumatic diseases: monocentric study of 691 patients. Semin. Arthritis Rheum. 47, 129\u2013132 (2017).","journal-title":"Semin. Arthritis Rheum."},{"key":"506_CR113","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejpain.2010.09.002","volume":"15","author":"G Affaitati","year":"2011","unstructured":"Affaitati, G. et al. Effects of treatment of peripheral pain generators in fibromyalgia patients. Eur. J. Pain 15, 61\u201369 (2011).","journal-title":"Eur. J. Pain"},{"key":"506_CR114","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1097\/j.pain.0000000000000285","volume":"156","author":"K Doppler","year":"2015","unstructured":"Doppler, K., Rittner, H. L., Deckart, M. & Sommer, C. Reduced dermal nerve fiber diameter in skin biopsies of patients with fibromyalgia. Pain 156, 2319\u20132325 (2015).","journal-title":"Pain"},{"key":"506_CR115","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1097\/j.pain.0000000000000311","volume":"156","author":"DJ Clauw","year":"2015","unstructured":"Clauw, D. J. What is the meaning of \u201csmall fiber neuropathy\u201d in fibromyalgia? Pain 156, 2115\u20132116 (2015).","journal-title":"Pain"},{"key":"506_CR116","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/nm.2234","volume":"16","author":"K Ren","year":"2010","unstructured":"Ren, K. & Dubner, R. Interactions between the immune and nervous systems in pain. Nat. Med. 16, 1267\u20131276 (2010).","journal-title":"Nat. Med."},{"key":"506_CR117","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/08916930701620035","volume":"41","author":"P Sarzi-Puttini","year":"2008","unstructured":"Sarzi-Puttini, P. et al. Anti-polymer antibodies are correlated with pain and fatigue severity in patients with fibromyalgia syndrome. Autoimmunity 41, 74\u201379 (2008).","journal-title":"Autoimmunity"},{"key":"506_CR118","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1007\/s10067-007-0636-8","volume":"26","author":"L Bazzichi","year":"2007","unstructured":"Bazzichi, L. et al. Association between thyroid autoimmunity and fibromyalgic disease severity. Clin. Rheumatol. 26, 2115\u20132120 (2007).","journal-title":"Clin. Rheumatol."},{"key":"506_CR119","first-page":"S118","volume":"29","author":"G Cassisi","year":"2011","unstructured":"Cassisi, G., Sarzi-Puttini, P. & Cazzola, M. Chronic widespread pain and fibromyalgia: could there be some relationships with infections and vaccinations? Clin. Exp. Rheumatol. 29, S118\u2013S126 (2011).","journal-title":"Clin. Exp. Rheumatol."},{"key":"506_CR120","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/art.38972","volume":"67","author":"GP Wormser","year":"2015","unstructured":"Wormser, G. P. et al. Long-term assessment of fibromyalgia in patients with culture-confirmed Lyme disease. Arthritis Rheumatol. 67, 837\u2013839 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"506_CR121","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/acr.20328","volume":"63","author":"W H\u00e4user","year":"2011","unstructured":"H\u00e4user, W., Kosseva, M., \u00dcceyler, N., Klose, P. & Sommer, C. Emotional, physical, and sexual abuse in fibromyalgia syndrome: a systematic review with meta-analysis. Arthritis Care Res. 63, 808\u2013820 (2011).","journal-title":"Arthritis Care Res."},{"key":"506_CR122","first-page":"S86","volume":"33","author":"W H\u00e4user","year":"2015","unstructured":"H\u00e4user, W. et al. Self-reported childhood maltreatment, lifelong traumatic events and mental disorders in fibromyalgia syndrome: a comparison of US and German outpatients. Clin. Exp. Rheumatol. 33, S86\u2013S92 (2015).","journal-title":"Clin. Exp. Rheumatol."},{"key":"506_CR123","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1001\/jama.2009.1091","volume":"302","author":"ML Paras","year":"2009","unstructured":"Paras, M. L. et al. Sexual abuse and lifetime diagnosis of somatic disorders. JAMA 302, 550 (2009).","journal-title":"JAMA"},{"key":"506_CR124","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.semarthrit.2013.03.004","volume":"43","author":"M Meeus","year":"2013","unstructured":"Meeus, M. et al. Heart rate variability in patients with fibromyalgia and patients with chronic fatigue syndrome: a systematic review. Semin. Arthritis Rheum. 43, 279\u2013287 (2013).","journal-title":"Semin. Arthritis Rheum."},{"key":"506_CR125","first-page":"1787","volume":"32","author":"R Furlan","year":"2005","unstructured":"Furlan, R. et al. Abnormalities of cardiovascular neural control and reduced orthostatic tolerance in patients with primary fibromyalgia. J. Rheumatol. 32, 1787\u20131793 (2005).","journal-title":"J. Rheumatol."},{"key":"506_CR126","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/RHU.0000000000000089","volume":"20","author":"LA Mart\u00ednez-Mart\u00ednez","year":"2014","unstructured":"Mart\u00ednez-Mart\u00ednez, L. A., Mora, T., Vargas, A., Fuentes-Iniestra, M. & Mart\u00ednez-Lav\u00edn, M. Sympathetic nervous system dysfunction in fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, and interstitial cystitis: a review of case-control studies. J. Clin. Rheumatol. 20, 146\u2013150 (2014).","journal-title":"J. Clin. Rheumatol."},{"key":"506_CR127","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0049-0172(00)80008-6","volume":"29","author":"M Mart\u00ednez-Lav\u00edn","year":"2000","unstructured":"Mart\u00ednez-Lav\u00edn, M. & Hermosillo, A. G. Autonomic nervous system dysfunction may explain the multisystem features of fibromyalgia. Semin. Arthritis Rheum. 29, 197\u2013199 (2000).","journal-title":"Semin. Arthritis Rheum."},{"key":"506_CR128","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3389\/fnins.2018.00228","volume":"12","author":"L Carnevali","year":"2018","unstructured":"Carnevali, L., Koenig, J., Sgoifo, A. & Ottaviani, C. Autonomic and brain morphological predictors of stress resilience. Front. Neurosci. 12, 228 (2018).","journal-title":"Front. Neurosci."},{"key":"506_CR129","doi-asserted-by":"crossref","first-page":"13746","DOI":"10.1523\/JNEUROSCI.3687-09.2009","volume":"29","author":"R Rodriguez-Raecke","year":"2009","unstructured":"Rodriguez-Raecke, R., Niemeier, A., Ihle, K., Ruether, W. & May, A. Brain gray matter decrease in chronic pain is the consequence and not the cause of pain. J. Neurosci. 29, 13746\u201313750 (2009).","journal-title":"J. Neurosci."},{"key":"506_CR130","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6584753","author":"AC Tan","year":"2019","unstructured":"Tan, A. C., Jaaniste, T. & Champion, D. Chronic widespread pain and fibromyalgia syndrome: life-course risk markers in young people. Pain Res. Manag. https:\/\/doi.org\/10.1155\/2019\/6584753 (2019).","journal-title":"Pain Res. Manag."},{"key":"506_CR131","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1177\/1524838011416375","volume":"12","author":"RW Thompson","year":"2011","unstructured":"Thompson, R. W., Arnkoff, D. B. & Glass, C. R. Conceptualizing mindfulness and acceptance as components of psychological resilience to trauma. Trauma Violence Abuse 12, 220\u2013235 (2011).","journal-title":"Trauma Violence Abuse"},{"key":"506_CR132","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1111\/jep.13052","volume":"24","author":"JM Bennett","year":"2018","unstructured":"Bennett, J. M., Rohleder, N. & Sturmberg, J. P. Biopsychosocial approach to understanding resilience: Stress habituation and where to intervene. J. Eval. Clin. Pract. 24, 1339\u20131346 (2018).","journal-title":"J. Eval. Clin. Pract."},{"key":"506_CR133","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11916-016-0567-7","volume":"20","author":"AL Hassett","year":"2016","unstructured":"Hassett, A. L. & Finan, P. H. The role of resilience in the clinical management of chronic pain. Curr. Pain. Headache Rep. 20, 39 (2016).","journal-title":"Curr. Pain. Headache Rep."},{"key":"506_CR134","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1126\/science.847460","volume":"196","author":"G Engel","year":"1977","unstructured":"Engel, G. The need for a new medical model: a challenge for biomedicine. Science 196, 129\u2013136 (1977).","journal-title":"Science"},{"key":"506_CR135","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/brain\/awh098","volume":"127","author":"RH Gracely","year":"2004","unstructured":"Gracely, R. H. et al. Pain catastrophizing and neural responses to pain among persons with fibromyalgia. Brain 127, 835\u2013843 (2004).","journal-title":"Brain"},{"key":"506_CR136","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1093\/pm\/pny008","volume":"19","author":"LD Ellingson","year":"2018","unstructured":"Ellingson, L. D., Stegner, A. J., Schwabacher, I. J., Lindheimer, J. B. & Cook, D. B. Catastrophizing interferes with cognitive modulation of pain in women with fibromyalgia. Pain Med. 19, 2408\u20132422 (2018).","journal-title":"Pain Med."},{"key":"506_CR137","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0304-3959(02)00417-7","volume":"102","author":"ME Geisser","year":"2003","unstructured":"Geisser, M. E. et al. Perception of noxious and innocuous heat stimulation among healthy women and women with fibromyalgia: association with mood, somatic focus, and catastrophizing. Pain 102, 243\u2013250 (2003).","journal-title":"Pain"},{"key":"506_CR138","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s10880-018-9543-1","volume":"25","author":"MJ Lami","year":"2018","unstructured":"Lami, M. J., Mart\u00ednez, M. P., Mir\u00f3, E., S\u00e1nchez, A. I. & Guzm\u00e1n, M. A. Catastrophizing, acceptance, and coping as mediators between pain and emotional distress and disability in fibromyalgia. J. Clin. Psychol. Med. Settings 25, 80\u201392 (2018).","journal-title":"J. Clin. Psychol. Med. Settings"},{"key":"506_CR139","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000002040","author":"P Broadbent","year":"2020","unstructured":"Broadbent, P., Liossi, C. & Schoth, D. E. Attentional bias to somatosensory stimuli in chronic pain patients: a systematic review and meta-analysis. Pain https:\/\/doi.org\/10.1097\/j.pain.0000000000002040 (2020).","journal-title":"Pain"},{"key":"506_CR140","first-page":"112","volume":"35","author":"A Alciati","year":"2017","unstructured":"Alciati, A. et al. Childhood adversities in patients with fibromyalgia: are they related to comorbid lifetime major depression? Clin. Exp. Rheumatol. 35, 112\u2013118 (2017).","journal-title":"Clin. Exp. Rheumatol."},{"key":"506_CR141","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0033-3182(99)71272-7","volume":"40","author":"SA Epstein","year":"1999","unstructured":"Epstein, S. A. et al. Psychiatric disorders in patients with fibromyalgia. Psychosomatics 40, 57\u201363 (1999).","journal-title":"Psychosomatics"},{"key":"506_CR142","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4081\/reumatismo.2012.268","volume":"64","author":"A Alciati","year":"2012","unstructured":"Alciati, A., Sgiarovello, P., Atzeni, F. & Sarzi-Puttini, P. Psychiatric problems in fibromyalgia: clinical and neurobiological links between mood disorders and fibromyalgia. Reumatismo 64, 268\u2013274 (2012).","journal-title":"Reumatismo"},{"key":"506_CR143","first-page":"143","volume":"30","author":"P Sarzi-Puttini","year":"2012","unstructured":"Sarzi-Puttini, P. et al. Dysfunctional syndromes and fibromyalgia: a 2012 critical digest. Clin. Exp. Rheumatol. 30, 143\u2013151 (2012).","journal-title":"Clin. Exp. Rheumatol."},{"key":"506_CR144","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrrheum.2015.56","volume":"11","author":"EHS Choy","year":"2015","unstructured":"Choy, E. H. S. The role of sleep in pain and fibromyalgia. Nat. Rev. Rheumatol. 11, 513\u2013520 (2015).","journal-title":"Nat. Rev. Rheumatol."},{"key":"506_CR145","first-page":"74","volume":"35","author":"M Rizzi","year":"2017","unstructured":"Rizzi, M. et al. Influence of autonomic nervous system dysfunction in the genesis of sleep disorders in fibromyalgia patients. Clin. Exp. Rheumatol. 35, 74\u201380 (2017).","journal-title":"Clin. Exp. Rheumatol."},{"key":"506_CR146","first-page":"1586","volume":"26","author":"MJ Lentz","year":"1999","unstructured":"Lentz, M. J., Landis, C. A., Rothermel, J. & Shaver, J. L. Effects of selective slow wave sleep disruption on musculoskeletal pain and fatigue in middle aged women. J. Rheumatol. 26, 1586\u20131592 (1999).","journal-title":"J. Rheumatol."},{"key":"506_CR147","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/sleep\/30.4.494","volume":"30","author":"MT Smith","year":"2007","unstructured":"Smith, M. T., Edwards, R. R., McCann, U. D. & Haythornthwaite, J. A. The effects of sleep deprivation on pain inhibition and spontaneous pain in women. Sleep 30, 494\u2013505 (2007).","journal-title":"Sleep"},{"key":"506_CR148","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00006842-197507000-00008","volume":"37","author":"H Moldofsky","year":"1975","unstructured":"Moldofsky, H., Scarisbrick, P., England, R. & Smythe, H. Musculosketal symptoms and non-REM sleep disturbance in patients with \u201cfibrositis syndrome\u201d and healthy subjects. Psychosom. Med. 37, 341\u2013351 (1975).","journal-title":"Psychosom. Med."},{"key":"506_CR149","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13760-014-0312-0","volume":"115","author":"P Yalinay Dikmen","year":"2015","unstructured":"Yalinay Dikmen, P., Yavuz, B. G. & Aydinlar, E. I. The relationships between migraine, depression, anxiety, stress, and sleep disturbances. Acta Neurol. Belg. 115, 117\u2013122 (2015).","journal-title":"Acta Neurol. Belg."},{"key":"506_CR150","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/jsr.12254","volume":"24","author":"B Sivertsen","year":"2015","unstructured":"Sivertsen, B., Harvey, A. G., Pallesen, S. & Hysing, M. Mental health problems in adolescents with delayed sleep phase: results from a large population-based study in Norway. J. Sleep. Res. 24, 11\u201318 (2015).","journal-title":"J. Sleep. Res."},{"key":"506_CR151","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.biopsycho.2015.11.004","volume":"113","author":"L Haase","year":"2016","unstructured":"Haase, L. et al. When the brain does not adequately feel the body: links between low resilience and interoception. Biol. Psychol. 113, 37\u201345 (2016).","journal-title":"Biol. Psychol."},{"key":"506_CR152","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/7261468","author":"EM Giusti","year":"2017","unstructured":"Giusti, E. M., Castelnuovo, G., & Molinari, E. Differences in multidisciplinary and interdisciplinary treatment programs for fibromyalgia: a mapping review. Pain Res. Manag. https:\/\/doi.org\/10.1155\/2017\/7261468 (2017).","journal-title":"Pain Res. Manag."},{"key":"506_CR153","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.berh.2019.01.019","volume":"32","author":"O Gendelman","year":"2018","unstructured":"Gendelman, O. et al. Time to diagnosis of fibromyalgia and factors associated with delayed diagnosis in primary care. Best Pract. Res. Clin. Rheumatol. 32, 489\u2013499 (2018).","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"506_CR154","first-page":"301","volume":"55","author":"MC Garc\u00eda-R\u00edos","year":"2019","unstructured":"Garc\u00eda-R\u00edos, M. C. et al. Effectiveness of health education in patients with fibromyalgia: a systematic review. Eur. J. Phys. Rehabil. Med. 55, 301\u2013313 (2019).","journal-title":"Eur. J. Phys. Rehabil. Med."},{"key":"506_CR155","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.2014.3266","volume":"311","author":"DJ Clauw","year":"2014","unstructured":"Clauw, D. J. Fibromyalgia: a clinical review. JAMA 311, 1547\u20131555 (2014).","journal-title":"JAMA"},{"key":"506_CR156","doi-asserted-by":"crossref","first-page":"53","DOI":"10.31887\/DCNS.2018.20.1\/whauser","volume":"20","author":"W H\u00e4user","year":"2018","unstructured":"H\u00e4user, W. & Fitzcharles, M. A. Facts and myths pertaining to fibromyalgia. Dialogues Clin. Neurosci. 20, 53\u201362 (2018).","journal-title":"Dialogues Clin. Neurosci."},{"key":"506_CR157","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1503\/cmaj.121414","volume":"185","author":"MA Fitzcharles","year":"2013","unstructured":"Fitzcharles, M. A., Ste-Marie, P. A. & Pereira, J. X. Fibromyalgia: evolving concepts over the past 2 decades. Can. Med. Assoc. J. 185, 645\u2013651 (2013).","journal-title":"Can. Med. Assoc. J."},{"key":"506_CR158","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/msc.1470","volume":"18","author":"J Pearson","year":"2020","unstructured":"Pearson, J. et al. Fibromyalgia self-management: mapping the behaviour change techniques used in a practice-based programme. Musculoskelet. Care 18, 372\u2013382 (2020).","journal-title":"Musculoskelet. Care"},{"key":"506_CR159","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jpain.2017.08.004","volume":"18","author":"A Schrepf","year":"2017","unstructured":"Schrepf, A. et al. Improvement in the spatial distribution of pain, somatic symptoms, and depression after a weight loss intervention. J. Pain 18, 1542\u20131550 (2017).","journal-title":"J. Pain"},{"key":"506_CR160","first-page":"CD003786","volume":"17","author":"AJ Busch","year":"2007","unstructured":"Busch, A. J., Barber, K. A. R., Overend, T. J., Peloso, P. M. J. & Schachter, C. L. Exercise for treating fibromyalgia syndrome. Cochrane Database Syst. Rev. 17, CD003786 (2007).","journal-title":"Cochrane Database Syst. Rev."},{"key":"506_CR161","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00296-019-04270-3","volume":"39","author":"T O\u2019Dwyer","year":"2019","unstructured":"O\u2019Dwyer, T., Maguire, S., Mockler, D., Durcan, L. & Wilson, F. Behaviour change interventions targeting physical activity in adults with fibromyalgia: a systematic review. Rheumatol. Int. 39, 805\u2013817 (2019).","journal-title":"Rheumatol. Int."},{"key":"506_CR162","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.biopha.2018.04.056","volume":"103","author":"G Bj\u00f8rklund","year":"2018","unstructured":"Bj\u00f8rklund, G., Dadar, M., Chirumbolo, S. & Aaseth, J. Fibromyalgia and nutrition: therapeutic possibilities? Biomed. Pharmacother. 103, 531\u2013538 (2018).","journal-title":"Biomed. Pharmacother."},{"key":"506_CR163","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.3390\/nu12092525","volume":"12","author":"G Pagliai","year":"2020","unstructured":"Pagliai, G., Giangrandi, I., Dinu, M., Sofi, F. & Colombini, B. Nutritional Interventions in the management of fibromyalgia syndrome. Nutrients 12, 2525 (2020).","journal-title":"Nutrients"},{"key":"506_CR164","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.berh.2015.04.024","volume":"29","author":"DJ Clauw","year":"2015","unstructured":"Clauw, D. J. Diagnosing and treating chronic musculoskeletal pain based on the underlying mechanism(s). Best Pract. Res. Clin. Rheumatol. 29, 6\u201319 (2015).","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"506_CR165","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/rheumatology\/keq354","volume":"50","author":"W H\u00e4user","year":"2011","unstructured":"H\u00e4user, W., Petzke, F., \u00dc\u00e7eyler, N. & Sommer, C. Comparative efficacy and acceptability of amitriptyline, duloxetine and milnacipran in fibromyalgia syndrome: a systematic review with meta-analysis. Rheumatology 50, 532\u2013543 (2011).","journal-title":"Rheumatology"},{"key":"506_CR166","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2165\/11598970-000000000-00000","volume":"26","author":"W H\u00e4user","year":"2012","unstructured":"H\u00e4user, W., Wolfe, F., T\u00f6lle, T., U\u00e7eyler, N. & Sommer, C. The role of antidepressants in the management of fibromyalgia syndrome: a systematic review and meta-analysis. CNS Drugs 26, 297\u2013307 (2012).","journal-title":"CNS Drugs"},{"key":"506_CR167","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1517\/14656566.2015.1047343","volume":"16","author":"EP Calandre","year":"2015","unstructured":"Calandre, E. P., Rico-Villademoros, F. & Slim, M. An update on pharmacotherapy for the treatment of fibromyalgia. Expert. Opin. Pharmacother. 16, 1347\u20131368 (2015).","journal-title":"Expert. Opin. Pharmacother."},{"key":"506_CR168","first-page":"CD010292","volume":"31","author":"W H\u00e4user","year":"2013","unstructured":"H\u00e4user, W., Urr\u00fatia, G., Tort, S., \u00dc\u00e7eyler, N. & Walitt, B. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome. Cochrane Database Syst. Rev. 31, CD010292 (2013).","journal-title":"Cochrane Database Syst. Rev."},{"key":"506_CR169","first-page":"CD007115","volume":"3","author":"MP Lunn","year":"2014","unstructured":"Lunn, M. P., Hughes, R. A. & Wiffen, P. J. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database Syst. Rev. 3, CD007115 (2014).","journal-title":"Cochrane Database Syst. Rev."},{"key":"506_CR170","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.2147\/DDDT.S162810","volume":"12","author":"G Pickering","year":"2018","unstructured":"Pickering, G. et al. Milnacipran poorly modulates pain in patients suffering from fibromyalgia: a randomized double-blind controlled study. Drug Des. Devel. Ther. 12, 2485\u20132496 (2018).","journal-title":"Drug Des. Devel. Ther."},{"key":"506_CR171","first-page":"CD010782","volume":"16","author":"N \u00dc\u00e7eyler","year":"2013","unstructured":"\u00dc\u00e7eyler, N., Sommer, C., Walitt, B. & H\u00e4user, W. Anticonvulsants for fibromyalgia. Cochrane Database Syst. Rev. 16, CD010782 (2013).","journal-title":"Cochrane Database Syst. Rev."},{"key":"506_CR172","first-page":"CD012188","volume":"1","author":"TE Cooper","year":"2017","unstructured":"Cooper, T. E., Derry, S., Wiffen, P. J. & Moore, R. A. Gabapentin for fibromyalgia pain in adults. Cochrane Database Syst. Rev. 1, CD012188 (2017).","journal-title":"Cochrane Database Syst. Rev."},{"key":"506_CR173","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/rheumatology\/kep432","volume":"49","author":"S Straube","year":"2010","unstructured":"Straube, S., Derry, S., Moore, R. A. & McQuay, H. J. Pregabalin in fibromyalgia: meta-analysis of efficacy and safety from company clinical trial reports. Rheumatology 49, 706\u2013715 (2010).","journal-title":"Rheumatology"},{"key":"506_CR174","first-page":"CD011790","volume":"9","author":"S Derry","year":"2016","unstructured":"Derry, S. et al. Pregabalin for pain in fibromyalgia in adults. Cochrane Database Syst. Rev. 9, CD011790 (2016).","journal-title":"Cochrane Database Syst. Rev."},{"key":"506_CR175","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1080\/14737175.2018.1508344","volume":"18","author":"A Alciati","year":"2018","unstructured":"Alciati, A. et al. Controlled-release pregabalin in the treatment of fibromyalgia. Expert. Rev. Neurother. 18, 617\u2013623 (2018).","journal-title":"Expert. Rev. Neurother."},{"key":"506_CR176","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/art.20076","volume":"51","author":"JK Tofferi","year":"2004","unstructured":"Tofferi, J. K., Jackson, J. L. & O\u2019Malley, P. G. Treatment of fibromyalgia with cyclobenzaprine: a meta-analysis. Arthritis Rheum. 51, 9\u201313 (2004).","journal-title":"Arthritis Rheum."},{"key":"506_CR177","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2344\/0003-3006-62.1.31","volume":"62","author":"JA Giovannitti","year":"2015","unstructured":"Giovannitti, J. A., Thoms, S. M. & Crawford, J. J. Alpha-2 adrenergic receptor agonists: a review of current clinical applications. Anesth. Prog. 62, 31\u201338 (2015).","journal-title":"Anesth. Prog."},{"key":"506_CR178","doi-asserted-by":"crossref","first-page":"422","DOI":"10.36076\/ppj.2002\/5\/422","volume":"5","author":"GA Malanga","year":"2002","unstructured":"Malanga, G. A., Gwyn, M. W., Smith, R. & Miller, D. Tizanidine is effective in the treatment of myofascial pain syndrome. Pain Physician 5, 422\u2013432 (2002).","journal-title":"Pain Physician"},{"key":"506_CR179","first-page":"365","volume":"78","author":"S See","year":"2008","unstructured":"See, S. & Ginzburg, R. Choosing a skeletal muscle relaxant. Am. Fam. Physician 78, 365 (2008).","journal-title":"Am. Fam. Physician"},{"key":"506_CR180","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2217\/pmt-2016-0012","volume":"6","author":"GO Littlejohn","year":"2016","unstructured":"Littlejohn, G. O., Guymer, E. K. & Ngian, G.-S. Is there a role for opioids in the treatment of fibromyalgia? Pain Manag. 6, 347\u2013355 (2016).","journal-title":"Pain Manag."},{"key":"506_CR181","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/art.37734","volume":"65","author":"J Younger","year":"2013","unstructured":"Younger, J., Noor, N., McCue, R. & MacKey, S. Low-dose naltrexone for the treatment of fibromyalgia: findings of a small, randomized, double-blind, placebo-controlled, counterbalanced, crossover trial assessing daily pain levels. Arthritis Rheum. 65, 529\u2013538 (2013).","journal-title":"Arthritis Rheum."},{"key":"506_CR182","volume":"24","author":"PS Kim","year":"2020","unstructured":"Kim, P. S. & Fishman, M. A. Low-dose naltrexone for chronic pain: update and systemic review. Curr. Pain Headache Rep. 24, 64 (2020).","journal-title":"Curr. Pain Headache Rep."},{"key":"506_CR183","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/RHU.0b013e3182863447","volume":"19","author":"JT Painter","year":"2013","unstructured":"Painter, J. T. & Crofford, L. J. Chronic opioid use in fibromyalgia syndrome: a clinical review. J. Clin. Rheumatol. 19, 72\u201377 (2013).","journal-title":"J. Clin. Rheumatol."},{"key":"506_CR184","first-page":"280","volume":"59","author":"M Cazzola","year":"2007","unstructured":"Cazzola, M., Sarzi-Puttini, P., Buskila, D. & Atzeni, F. [Pharmacological treatment of fibromyalgia]. Reumatismo 59, 280\u2013291 (2007).","journal-title":"Reumatismo"},{"key":"506_CR185","first-page":"S79","volume":"35","author":"DJ Clauw","year":"2017","unstructured":"Clauw, D. J. & Hassett, A. L. The role of centralised pain in osteoarthritis. Clin. Exp. Rheumatol. 35, S79\u2013S84 (2017).","journal-title":"Clin. Exp. Rheumatol."},{"key":"506_CR186","first-page":"529","volume":"23","author":"H Moldofsky","year":"1996","unstructured":"Moldofsky, H., Lue, F. A., Mously, C., Roth-Schechter, B. & Reynolds, W. J. The effect of zolpidem in patients with fibromyalgia: a dose ranging, double blind, placebo controlled, modified crossover study. J. Rheumatol. 23, 529\u2013533 (1996).","journal-title":"J. Rheumatol."},{"key":"506_CR187","first-page":"CD011804","volume":"2016","author":"B Walitt","year":"2016","unstructured":"Walitt, B., Klose, P., \u00dc\u00e7eyler, N., Phillips, T. & H\u00e4user, W. Antipsychotics for fibromyalgia in adults. Cochrane Database Syst. Rev. 2016, CD011804 (2016).","journal-title":"Cochrane Database Syst. Rev."},{"key":"506_CR188","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1007\/s00213-013-3422-0","volume":"231","author":"EP Calandre","year":"2014","unstructured":"Calandre, E. P. et al. Quetiapine extended-release (Seroquel-XR) versus amitriptyline monotherapy for treating patients with fibromyalgia: a 16-week, randomized, flexible-dose, open-label trial. Psychopharmacology 231, 2525\u20132531 (2014).","journal-title":"Psychopharmacology"},{"key":"506_CR189","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1089\/can.2015.0010","volume":"1","author":"TB Strouse","year":"2016","unstructured":"Strouse, T. B. Cannabinoids in medical practice. Cannabis Cannabinoid Res. 1, 38\u201343 (2016).","journal-title":"Cannabis Cannabinoid Res."},{"key":"506_CR190","first-page":"CD011694","volume":"7","author":"B Walitt","year":"2016","unstructured":"Walitt, B., Klose, P., Ma, F., Phillips, T. & H\u00e4user, W. Cannabinoids for fibromyalgia (Review). Cochrane Database Syst. Rev. 7, CD011694 (2016).","journal-title":"Cochrane Database Syst. Rev."},{"key":"506_CR191","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1097\/j.pain.0000000000001293","volume":"159","author":"M Farrell","year":"2018","unstructured":"Farrell, M. et al. Cannabis and cannabinoids for the treatment of people with chronic noncancer pain conditions. Pain 159, 1932\u20131954 (2018).","journal-title":"Pain"},{"key":"506_CR192","doi-asserted-by":"crossref","first-page":"E755","DOI":"10.36076\/ppj.20.5.E755","volume":"20","author":"J Aviram","year":"2017","unstructured":"Aviram, J. & Samuelly-Leichtag, G. Efficacy of cannabis-based medicines for pain management: a systematic review and meta- analysis of randomized controlled trials. Pain Physician 20, E755\u2013E796 (2017).","journal-title":"Pain Physician"},{"key":"506_CR193","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1089\/can.2017.0017","volume":"2","author":"KP Hill","year":"2017","unstructured":"Hill, K. P., Palastro, M. D., Johnson, B. & Ditre, J. W. Cannabis and pain: a clinical review. Cannabis Cannabinoid Res. 2, 96\u2013104 (2017).","journal-title":"Cannabis Cannabinoid Res."},{"key":"506_CR194","volume":"6","author":"J Fiz","year":"2011","unstructured":"Fiz, J., Dur\u00e0n, M., Capell\u00e0, D., Carbonell, J. & Farr\u00e9, M. Cannabis use in patients with fibromyalgia: effect on symptoms relief and health-related quality of life. PLoS ONE 6, e18440 (2011).","journal-title":"PLoS ONE"},{"key":"506_CR195","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1080\/1744666X.2019.1665997","volume":"15","author":"P Sarzi-Puttini","year":"2019","unstructured":"Sarzi-Puttini, P. et al. Medical cannabis and cannabinoids in rheumatology: where are we now? Expert Rev. Clin. Immunol. 15, 1019\u20131032 (2019).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"506_CR196","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/RHU.0000000000000702","volume":"24","author":"G Habib","year":"2018","unstructured":"Habib, G. & Artul, S. Medical cannabis for the treatment of fibromyalgia. J. Clin. Rheumatol. 24, 255\u2013258 (2018).","journal-title":"J. Clin. Rheumatol."},{"key":"506_CR197","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/j.pain.0000000000001464","volume":"160","author":"T van de Donk","year":"2019","unstructured":"van de Donk, T. et al. An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia. Pain 160, 860\u2013869 (2019).","journal-title":"Pain"},{"key":"506_CR198","first-page":"13","volume":"37","author":"M Yassin","year":"2019","unstructured":"Yassin, M., Oron, A. & Robinson, D. Effect of adding medical cannabis to analgesic treatment in patients with low back pain related to fibromyalgia: an observational cross-over single centre study. Clin. Exp. Rheumatol. 37, 13\u201320 (2019).","journal-title":"Clin. Exp. Rheumatol."},{"key":"506_CR199","first-page":"53","volume":"38","author":"V Giorgi","year":"2020","unstructured":"Giorgi, V. et al. Adding medical cannabis to standard analgesic treatment for fibromyalgia: a prospective observational study. Clin. Exp. Rheumatol. 38, 53\u201359 (2020).","journal-title":"Clin. Exp. Rheumatol."},{"key":"506_CR200","unstructured":"National Pain Report. Marijuana rated most effective for treating fibromyalgia, http:\/\/nationalpainreport.com\/marijuana-rated-most-effective-for-treating-fibromyalgia-8823638.html (2014)."},{"key":"506_CR201","first-page":"297","volume":"20","author":"FA Rathore","year":"2020","unstructured":"Rathore, F. A. & Afridi, A. Is combination pharmacotherapy effective for management of fibromyalgia in adults? \u2014 a Cochrane Review summary with commentary. J. Musculoskelet. Neuronal Interact. 20, 297\u2013300 (2020).","journal-title":"J. Musculoskelet. Neuronal Interact."},{"key":"506_CR202","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nrrheum.2009.25","volume":"5","author":"CS Boomershine","year":"2009","unstructured":"Boomershine, C. S. & Crofford, L. J. A symptom-based approach to pharmacologic management of fibromyalgia. Nat. Rev. Rheumatol. 5, 191\u2013199 (2009).","journal-title":"Nat. Rev. Rheumatol."},{"key":"506_CR203","first-page":"CD010585","volume":"2018","author":"J Thorpe","year":"2018","unstructured":"Thorpe, J., Shum, B., Ra, M., Pj, W. & Gilron, I. Combination pharmacotherapy for the treatment of fibromyalgia in adults (Review). Cochrane Database Syst. Rev. 2018, CD010585 (2018).","journal-title":"Cochrane Database Syst. Rev."},{"key":"506_CR204","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/1759720X13483894","volume":"5","author":"PJ Mease","year":"2013","unstructured":"Mease, P. J. et al. Milnacipran combined with pregabalin in fibromyalgia: a randomized, open-label study evaluating the safety and efficacy of adding milnacipran in patients with incomplete response to pregabalin. Ther. Adv. Musculoskelet. Dis. 5, 113\u2013126 (2013).","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"506_CR205","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1097\/j.pain.0000000000000558","volume":"157","author":"I Gilron","year":"2016","unstructured":"Gilron, I. et al. Combination of pregabalin with duloxetine for fibromyalgia. Pain 157, 1532\u20131540 (2016).","journal-title":"Pain"},{"key":"506_CR206","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3899\/jrheum.141196","volume":"42","author":"LM Arnold","year":"2015","unstructured":"Arnold, L. M. et al. Efficacy and safety of pregabalin in patients with fibromyalgia and comorbid depression taking concurrent antidepressant medication: a randomized, placebo-controlled study. J. Rheumatol. 42, 1237\u20131244 (2015).","journal-title":"J. Rheumatol."},{"key":"506_CR207","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/ejp.1121","volume":"22","author":"K Bernardy","year":"2018","unstructured":"Bernardy, K., Klose, P., Welsch, P. & H\u00e4user, W. Efficacy, acceptability and safety of cognitive behavioural therapies in fibromyalgia syndrome - A systematic review and meta-analysis of randomized controlled trials. Eur. J. Pain 22, 242\u2013260 (2018).","journal-title":"Eur. J. Pain"},{"key":"506_CR208","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000001120","author":"H Jacobs","year":"2019","unstructured":"Jacobs, H. et al. The impact of a group-based multidisciplinary rehabilitation program on the quality of life in patients with fibromyalgia: results from the QUALIFIBRO Study. J. Clin. Rheumatol. https:\/\/doi.org\/10.1097\/RHU.0000000000001120 (2019).","journal-title":"J. Clin. Rheumatol."},{"key":"506_CR209","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ejp.1284","volume":"23","author":"K Bernardy","year":"2019","unstructured":"Bernardy, K., Klose, P., Welsch, P. & H\u00e4user, W. Efficacy, acceptability and safety of Internet-delivered psychological therapies for fibromyalgia syndrome: a systematic review and meta-analysis of randomized controlled trials. Eur. J. Pain 23, 3\u201314 (2019).","journal-title":"Eur. J. Pain"},{"key":"506_CR210","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/ejp.564","volume":"18","author":"S Perrot","year":"2014","unstructured":"Perrot, S. & Russell, I. J. More ubiquitous effects from non-pharmacologic than from pharmacologic treatments for fibromyalgia syndrome: a meta-analysis examining six core symptoms. Eur. J. Pain 18, 1067\u20131080 (2014).","journal-title":"Eur. J. Pain"},{"key":"506_CR211","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.3390\/ijms19061687","volume":"19","author":"I G\u00e1lvez","year":"2018","unstructured":"G\u00e1lvez, I., Torres-Piles, S. & Ortega-Rinc\u00f3n, E. Balneotherapy, immune system, and stress response: a hormetic strategy? Int. J. Mol. Sci. 19, 1687 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"506_CR212","doi-asserted-by":"crossref","first-page":"R141","DOI":"10.1186\/ar4603","volume":"16","author":"J Naumann","year":"2014","unstructured":"Naumann, J. & Sadaghiani, C. Therapeutic benefit of balneotherapy and hydrotherapy in the management of fibromyalgia syndrome: a qualitative systematic review and meta-analysis of randomized controlled trials. Arthritis Res. Ther. 16, R141 (2014).","journal-title":"Arthritis Res. Ther."},{"key":"506_CR213","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1007\/s10067-018-4117-z","volume":"37","author":"A Fioravanti","year":"2018","unstructured":"Fioravanti, A. et al. Is balneotherapy effective for fibromyalgia? Results from a 6-month double-blind randomized clinical trial. Clin. Rheumatol. 37, 2203\u20132212 (2018).","journal-title":"Clin. Rheumatol."},{"key":"506_CR214","doi-asserted-by":"publisher","unstructured":"Honda Y. et al. Effects of physical-agent pain relief modalities for fibromyalgia patients: a systematic review and meta-analysis of randomized controlled trials. Pain Res. Manag. https:\/\/doi.org\/10.1155\/2018\/2930632 (2018).","DOI":"10.1155\/2018\/2930632"},{"key":"506_CR215","doi-asserted-by":"crossref","first-page":"162","DOI":"10.5606\/ArchRheumatol.2016.5751","volume":"31","author":"EE Kurt","year":"2016","unstructured":"Kurt, E. E., Ko\u00e7ak, F. A., Erdem, H. R., Tuncay, F. & Kelez, F. Which non-pharmacological treatment is more effective on clinical parameters in patients with fibromyalgia: balneotherapy or aerobic exercise? Arch. Rheumatol. 31, 162\u2013169 (2016).","journal-title":"Arch. Rheumatol."},{"key":"506_CR216","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4137\/CMAMD.S8797","volume":"5","author":"GM Guidelli","year":"2012","unstructured":"Guidelli, G. M., Tenti, S., de Nobili, E. & Fioravanti, A. Fibromyalgia syndrome and spa therapy: myth or reality? Clin. Med. Insights Arthritis Musculoskelet. Disord. 5, 19\u201326 (2012).","journal-title":"Clin. Med. Insights Arthritis Musculoskelet. Disord."},{"key":"506_CR217","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00296-012-2360-1","volume":"33","author":"J Langhorst","year":"2013","unstructured":"Langhorst, J., Klose, P., Dobos, G. J., Bernardy, K. & H\u00e4user, W. Efficacy and safety of meditative movement therapies in fibromyalgia syndrome: a systematic review and meta-analysis of randomized controlled trials. Rheumatol. Int. 33, 193\u2013207 (2013).","journal-title":"Rheumatol. Int."},{"key":"506_CR218","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2147\/JPR.S32297","volume":"6","author":"SD Mist","year":"2013","unstructured":"Mist, S. D., Firestone, K. A. & Jones, K. D. Complementary and alternative exercise for fibromyalgia: a meta-analysis. J. Pain Res. 6, 247\u2013260 (2013).","journal-title":"J. Pain Res."},{"key":"506_CR219","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctim.2019.07.007","volume":"46","author":"C-A Cheng","year":"2019","unstructured":"Cheng, C.-A. et al. Effectiveness of Tai Chi on fibromyalgia patients: a meta-analysis of randomized controlled trials. Complement. Ther. Med. 46, 1\u20138 (2019).","journal-title":"Complement. Ther. Med."},{"key":"506_CR220","doi-asserted-by":"crossref","first-page":"k851","DOI":"10.1136\/bmj.k851","volume":"360","author":"C Wang","year":"2018","unstructured":"Wang, C. et al. Effect of tai chi versus aerobic exercise for fibromyalgia: comparative effectiveness randomized controlled trial. BMJ 360, k851 (2018).","journal-title":"BMJ"},{"key":"506_CR221","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/bjhp.12224","volume":"22","author":"W Van Gordon","year":"2017","unstructured":"Van Gordon, W., Shonin, E., Dunn, T. J., Garcia-Campayo, J. & Griffiths, M. D. Meditation awareness training for the treatment of fibromyalgia syndrome: a randomized controlled trial. Br. J. Health Psychol. 22, 186\u2013206 (2017).","journal-title":"Br. J. Health Psychol."},{"key":"506_CR222","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221897","volume":"14","author":"T Haugmark","year":"2019","unstructured":"Haugmark, T., Hagen, K. B., Smedslund, G. & Zangi, H. A. Mindfulness- and acceptance-based interventions for patients with fibromyalgia \u2014 a systematic review and meta-analyses. PLoS One 14, e0221897 (2019).","journal-title":"PLoS One"},{"key":"506_CR223","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jpsychores.2013.10.010","volume":"75","author":"R Lauche","year":"2013","unstructured":"Lauche, R., Cramer, H., Dobos, G., Langhorst, J. & Schmidt, S. A systematic review and meta-analysis of mindfulness-based stress reduction for the fibromyalgia syndrome. J. Psychosom. Res. 75, 500\u2013510 (2013).","journal-title":"J. Psychosom. Res."},{"key":"506_CR224","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.pain.2013.12.029","volume":"155","author":"JV Luciano","year":"2014","unstructured":"Luciano, J. V. et al. Effectiveness of group acceptance and commitment therapy for fibromyalgia: A 6-month randomized controlled trial (EFFIGACT study). Pain 155, 693\u2013702 (2014).","journal-title":"Pain"},{"key":"506_CR225","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jpain.2017.03.001","volume":"18","author":"JV Luciano","year":"2017","unstructured":"Luciano, J. V. et al. Cost-utility of group acceptance and commitment therapy for fibromyalgia versus recommended Drugs: an economic analysis alongside a 6-month randomized controlled trial conducted in Spain (EFFIGACT Study). J. Pain 18, 868\u2013880 (2017).","journal-title":"J. Pain"},{"key":"506_CR226","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.pain.2009.06.027","volume":"146","author":"MP Jensen","year":"2009","unstructured":"Jensen, M. P. Hypnosis for chronic pain management: a new hope. Pain 146, 235\u2013237 (2009).","journal-title":"Pain"},{"key":"506_CR227","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/ejp.933","volume":"21","author":"N Zech","year":"2017","unstructured":"Zech, N., Hansen, E., Bernardy, K. & H\u00e4user, W. Efficacy, acceptability and safety of guided imagery\/hypnosis in fibromyalgia \u2014 a systematic review and meta-analysis of randomized controlled trials. Eur. J. Pain 21, 217\u2013227 (2017).","journal-title":"Eur. J. Pain"},{"key":"506_CR228","first-page":"CD007070","volume":"2013","author":"JC Deare","year":"2013","unstructured":"Deare, J. C. et al. Acupuncture for treating fibromyalgia. Cochrane Database Syst. Rev. 2013, CD007070 (2013).","journal-title":"Cochrane Database Syst. Rev."},{"key":"506_CR229","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0254-6272(15)30037-6","volume":"34","author":"B Yang","year":"2014","unstructured":"Yang, B. et al. Efficacy of acupuncture on fibromyalgia syndrome: a meta-analysis. J. Tradit. Chin. Med. 34, 381\u2013391 (2014).","journal-title":"J. Tradit. Chin. Med."},{"key":"506_CR230","first-page":"63","volume":"37","author":"F Atzeni","year":"2019","unstructured":"Atzeni, F. et al. Hyperbaric oxygen treatment of fibromyalgia: a prospective observational clinical study. Clin. Exp. Rheumatol. 37, 63\u201369 (2019).","journal-title":"Clin. Exp. Rheumatol."},{"key":"506_CR231","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127012","volume":"10","author":"S Efrati","year":"2015","unstructured":"Efrati, S. et al. Hyperbaric oxygen therapy can diminish fibromyalgia syndrome \u2014 prospective clinical trial. PLoS ONE 10, e0127012 (2015).","journal-title":"PLoS ONE"},{"key":"506_CR232","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00702-019-02092-y","volume":"127","author":"X Moisset","year":"2020","unstructured":"Moisset, X., Lanteri-Minet, M. & Fontaine, D. Neurostimulation methods in the treatment of chronic pain. J. Neural Transm. 127, 673\u2013686 (2020).","journal-title":"J. Neural Transm."},{"key":"506_CR233","first-page":"S94","volume":"38","author":"F Atzeni","year":"2020","unstructured":"Atzeni, F. et al. Hyperbaric oxygen therapy in fibromyalgia and the diseases involving the central nervous system. Clin. Exp. Rheumatol. 38, S94\u2013S98 (2020).","journal-title":"Clin. Exp. Rheumatol."},{"key":"506_CR234","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fnagi.2019.00013","volume":"11","author":"F Brighina","year":"2019","unstructured":"Brighina, F. et al. Brain modulation by electric currents in fibromyalgia: a structured review on non-invasive approach with transcranial electrical stimulation. Front. Hum. Neurosci. 11, 13\u201340 (2019).","journal-title":"Front. Hum. Neurosci."},{"key":"506_CR235","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.pain.2011.01.034","volume":"152","author":"A Mhalla","year":"2011","unstructured":"Mhalla, A. et al. Long-term maintenance of the analgesic effects of transcranial magnetic stimulation in fibromyalgia. Pain 152, 1478\u20131485 (2011).","journal-title":"Pain"},{"key":"506_CR236","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/j.pain.0000000000000707","volume":"158","author":"M L\u00f3pez-Sol\u00e0","year":"2017","unstructured":"L\u00f3pez-Sol\u00e0, M. et al. Towards a neurophysiological signature for fibromyalgia. Pain 158, 34\u201347 (2017).","journal-title":"Pain"},{"key":"506_CR237","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/00325481.2019.1574403","volume":"131","author":"DJ Clauw","year":"2019","unstructured":"Clauw, D. J., Essex, M. N., Pitman, V. & Jones, K. D. Reframing chronic pain as a disease, not a symptom: rationale and implications for pain management. Postgrad. Med. 131, 185\u2013198 (2019).","journal-title":"Postgrad. Med."},{"key":"506_CR238","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nrrheum.2016.149","volume":"12","author":"R Bennett","year":"2016","unstructured":"Bennett, R. Fibromyalgia: shining a light on fibromyalgia treatment. Nat. Rev. Rheumatol. 12, 568\u2013569 (2016).","journal-title":"Nat. Rev. Rheumatol."},{"key":"506_CR239","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1111\/j.1526-4637.2006.00178.x","volume":"8","author":"LM Arnold","year":"2007","unstructured":"Arnold, L. M. Duloxetine and other antidepressants in the treatment of patients with fibromyalgia. Pain Med. 8, S63\u2013S74 (2007).","journal-title":"Pain Med."},{"key":"506_CR240","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1365-2710.2009.01144.x","volume":"35","author":"TG Tzellos","year":"2010","unstructured":"Tzellos, T. G. et al. Gabapentin and pregabalin in the treatment of fibromyalgia: a systematic review and a meta-analysis. J. Clin. Pharm. Ther. 35, 639\u2013656 (2010).","journal-title":"J. Clin. Pharm. Ther."},{"key":"506_CR241","first-page":"2","volume":"2017","author":"N \u00dc\u00e7eyler","year":"2017","unstructured":"\u00dc\u00e7eyler, N., Sommer, C., Walitt, B. & H\u00e4user, W. Anticonvulsants for fibromyalgia. Cochrane Database Syst. Rev. 2017, 2\u20135 (2017).","journal-title":"Cochrane Database Syst. Rev."},{"key":"506_CR242","doi-asserted-by":"crossref","first-page":"102409","DOI":"10.1016\/j.autrev.2019.102409","volume":"18","author":"P Sarzi-Puttini","year":"2019","unstructured":"Sarzi-Puttini, P. et al. Cannabinoids in the treatment of rheumatic diseases: pros and cons. Autoimmun. Rev. 18, 102409 (2019).","journal-title":"Autoimmun. Rev."},{"key":"506_CR243","unstructured":"Food and Drug Administration. Drug approval package: Cymbalta (duloxetine hydrochloride), 20, 30, and 60 mg capsules. FDA https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2010\/022516_cymbalta_tocEDT.cfm (2010)."},{"key":"506_CR244","unstructured":"IBM Micromedex. Duloxetine (Oral Route). Mayo Foundation for Medical Education and Research (MFMER). https:\/\/www.mayoclinic.org\/drugs-supplements\/duloxetine-oral-route\/side-effects\/drg-20067247 (2020)."},{"key":"506_CR245","unstructured":"IBM Micromedex. Milnacipran (Oral Route). Mayo Foundation for Medical Education and Research (MFMER)2. https:\/\/www.mayoclinic.org\/drugs-supplements\/milnacipran-oral-route\/side-effects\/drg-20072479 (2020)."},{"key":"506_CR246","unstructured":"U.S. Food and Drug Administration. Drug approval package: Savella (Milnacipran HCI) Tablets. FDA https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2009\/022256s000TOC.cfm (2009)."},{"key":"506_CR247","unstructured":"U.S. Food and Drug Administration. Drug approval package: Lyrica (pregabalin) Oral Solution 20 mg\/ml. FDA https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2010\/022488_lyrica_toc.cfm (2010)."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41584-020-00506-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-020-00506-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-020-00506-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T18:27:31Z","timestamp":1633631251000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-020-00506-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,6]]},"references-count":247,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["506"],"URL":"https:\/\/doi.org\/10.1038\/s41584-020-00506-w","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,6]]},"assertion":[{"value":"7 September 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}